Vaccine for people not for the profits of big pharma
World need vaccine for billions of people not make some billionaires
The People’s
Vaccine Alliance calculates that Pfizer, Johnson & Johnson and AstraZeneca
have paid out $26 billion in dividends and stock buybacks to their shareholders
in the past 12 months. This would be enough to pay to vaccinate at least 1.3bn
people, the equivalent of the population of Africa.
Oxfam International stated this in a press release issued Thursday, on behalf of Peoples Vaccine Alliance Asia, ahead of Big Pharma shareholder meeting this week. Oxfam is part of The Peoples’ Vaccine Alliance, a coalition of global and national organizations and activists united under a common aim of campaigning for a ‘People’s Vaccine’.
The call for a People’s Vaccine is backed by past and
present world leaders, health experts, faith leaders and economists. Peoples
Vaccine Alliance is working for free vaccine to all.
“Vaccine
apartheid is not a natural phenomenon but the result of governments stepping
back and allowing corporations to call the shots. Instead of creating new
vaccine billionaires we need to be vaccinating billions in developing
countries. It is appalling that Big Pharma is making huge pay-outs to wealthy
shareholders in the face of this global health emergency,” Marriott said.
The
shareholder meetings began on April 22 with Pfizer and Johnson and Johnson
followed by Moderna and Astrazeneca in the coming weeks. Protests are expected
outside the meetings in the US and UK while investors inside the meetings will
be presenting resolutions to expand vaccine access. There is a growing backlash
against the de facto privatisation of successful Covid-19 vaccines and pressure
on the pharma firms to openly license the intellectual property and share the
technology and know-how with qualified vaccine producers across the world.
While the
global economy remains frozen due to the slow and uneven vaccine rollout
worldwide, the soaring shares of vaccine makers has created a new wave of
billionaires.
The founder
of BioNTech, Ugur Sahin, is now worth $5.9 billion and Moderna CEO Stephane
Bancel $5.2 billion. According to regulatory filings, Bancel has cashed out
more than $142 million in Moderna stock since the pandemic began. Many other
investors have also become billionaires in the last few months, while the
International Chamber of Commerce projects a worst-case GDP loss of $9 trillion
due to global vaccine inequity.
While one in
four citizens of rich nations have had a vaccine, just one in 500 people in
poorer countries have done so, meaning the death toll continues to climb as the
virus remains out of control. Epidemiologists are predicting we have less than
a year before mutations could render the current vaccines ineffective.
One of the
reasons Pharma companies have been able to generate such large profits is
because of intellectual property rules that restrict production to a handful of
companies.
Post a Comment